Guidelines conflict for long-term opioid therapy in cancer survivors

July 24, 2018

(HealthDay)—Evidence is lacking about the need for and outcomes of long-term opioid therapy in cancer survivors, and contemporary guidelines offer conflicting recommendations, according to a viewpoint article recently published online in JAMA Oncology.

Noting that long-term use is prevalent among , Salimah H. Meghani, Ph.D., and Neha Vapiwala, M.D., from the University of Pennsylvania in Philadelphia, report on areas where the U.S. Centers for Disease Control and Prevention guidelines for prescribing opioids cause confusion for oncology clinicians.

The authors note that the CDC opioid guidelines distinguish between patients with undergoing treatment, to whom the guidelines do not apply, and those who have completed treatment, to whom they do apply, although pain levels are similar for both groups. Inconsistencies are noted in the CDC opioid guidelines and the National Comprehensive Cancer Network guidelines used by oncology clinicians, with the latter recommending long-acting opioid formulations and supplemental short-acting opioids in combination with long-acting opioids. The CDC opioid guidelines prefer non-pharmacologic therapy and non-opioid pharmacologic therapy for chronic pain, but robust evidence is lacking on the role of non-pharmacologic interventions in patients with cancer.

"This lack of evidence, coupled with conflicting and competing contemporary guidelines from diverse authoritative agencies and organizations, carries the potential to confuse, if not seriously jeopardize, pain management for patients with cancer who are living with moderate-to-severe pain, adding to an already appalling burden of unrelieved cancer ," the authors write.

Explore further: Conflicting guidance on opioid prescribing can jeopardize pain management for patients with cancer

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Conflicting guidance on opioid prescribing can jeopardize pain management for patients with cancer

May 31, 2018
Persistent pain and recurrent episodes of pain are common for those who are living with cancer, or for those undergoing cancer treatment. When used properly, prescription opioids have long been known to help combat pain experienced ...

Opioid prescribing guidelines frustrate cancer doctors as well as their patients

June 16, 2018
Opioids are a mainstay of pain relief for cancer patients, so it may not be surprising that many feel victimized by efforts to curb the nation's opioid addiction epidemic by limiting access to prescription painkillers.

Chronic pain remains the same or gets better after stopping opioid treatment: study

July 2, 2018
Stopping long-term opioid treatment does not make chronic, non-cancer-related pain worse and, in some cases, makes it better, Washington State University researchers have found.

Opioid prescribing at veterans hospitals varies widely in treating chronic pain

April 24, 2018
A new study of treatment options for military veterans with chronic pain has determined that care practices at Veterans Health Administration (VHA) facilities vary widely and could contribute to a veteran's likelihood of ...

Guidelines developed for pain management in cancer survivors

July 26, 2016
(HealthDay)—Guidelines have been developed for chronic pain management in adult cancer survivors. The American Society of Clinical Oncology Clinical Practice Guideline was published online July 25 in the Journal of Clinical ...

Opioid tapering may improve outcomes for chronic pain sufferers

July 17, 2017
Dose reduction may improve pain, function, and quality of life for patients prescribed long-term opioid therapy for chronic pain. Results of a systematic evidence review are published in Annals of Internal Medicine.

Recommended for you

US approves first generic competitor to Mylan's EpiPen

August 16, 2018
US regulators Thursday approved the first generic alternative for the EpiPen, a life-saving emergency allergy medicine, two years after soaring prices for the original version owned by Mylan stoked controversy.

Pregnant? Eating broccoli sprouts may reduce child's chances of breast cancer later in life

August 16, 2018
Researchers at the University of Alabama at Birmingham have found that a plant-based diet is more effective in preventing breast cancer later in life for the child if the mother consumed broccoli while pregnant. The 2018 ...

Scientists discover chemical which can kill glioblastoma cells

August 15, 2018
Aggressive brain tumour cells taken from patients self-destructed after being exposed to a chemical in laboratory tests, researchers have shown.

Three scientists share $500,000 prize for work on cancer therapy

August 15, 2018
Tumors once considered untreatable have disappeared and people previously given months to live are surviving for decades thanks to new therapies emerging from the work of three scientists chosen to receive a $500,000 medical ...

PARP inhibitor improves progression-free survival in patients with advanced breast cancers

August 15, 2018
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over ...

New clues into how 'trash bag of the cell' traps and seals off waste

August 15, 2018
The mechanics behind how an important process within the cell traps material before recycling it has puzzled scientists for years. But Penn State researchers have gained new insight into how this process seals off waste, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.